GCP
CCXI

GSA Capital Partners’s ChemoCentryx, Inc. CCXI Stock Holding History

GSA Capital Partners’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-16,747
Closed -$286K – 1944
2021
Q3 		$286K Buy
+16,747
New +$261K 0.03% 1056
2020
Q2 		– Sell
-5,114
Closed -$205K – 1261
2020
Q1 		$205K Sell
5,114
-12,624
-71% -$536K 0.05% 746
2019
Q4 		$702K Buy
+17,738
New +$311K 0.08% 424
2019
Q3 		– Sell
-60,622
Closed -$564K – 1818
2019
Q2 		$564K Sell
60,622
-30,778
-34% -$356K 0.06% 591
2019
Q1 		$1.27M Sell
91,400
-16,400
-15% -$188K 0.13% 182
2018
Q4 		$1.18M Sell
107,800
-57,000
-35% -$601K 0.14% 158
2018
Q3 		$2.08M Buy
164,800
+102,100
+163% +$1.23M 0.12% 225
2018
Q2 		$826K Buy
+62,700
New +$750K 0.04% 864

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

GSA Capital Partners's CCXI Position: Q4 2021 in Review

GSA Capital Partners sold out of ChemoCentryx, Inc. (CCXI) in Q4 2021, closing a stake of 16,747 shares — an estimated $286K sold.

GSA Capital Partners first reported a position in CCXI in Q2 2018 and held it in 8 quarters. The position peaked at $2.08M in Q3 2018. 190 funds tracked by Wall St. Rank hold CCXI as of Q4 2021.

  • GSA Capital Partners reported no remaining ChemoCentryx, Inc. position as of Q4 2021 after selling out during the quarter.
  • GSA Capital Partners sold 16,747 ChemoCentryx, Inc. shares in Q4 2021, an estimated $286K.
  • GSA Capital Partners first reported a position in ChemoCentryx, Inc. in Q2 2018 and held it in 8 quarters.
  • GSA Capital Partners's ChemoCentryx, Inc. position peaked at $2.08M in Q3 2018.
  • 190 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2021.

Based on GSA Capital Partners's 13F filing for Q4 2021, filed 14 Feb 2022.